In the rapidly evolving landscape of healthcare, genetic testing is emerging as a pivotal force, promising to transform patient care through precision medicine. The insights derived from our genetic codes hold the potential to not only prevent diseases but also optimize treatments and promote healthier living. Yet, as highlighted in a recent MedCity News article, the journey towards realizing this potential is fraught with challenges, particularly around patient privacy and data sharing.
The Role of Information Technology
A critical component in addressing these challenges is information technology security. Organizations are turning to certifications like HITRUST to establish standards for safeguarding sensitive information. By aligning with these standards, they can protect data while facilitating the sharing necessary to enhance medical knowledge and patient care.
Collaborative Efforts and Data Sharing
Collaboration is at the heart of advancing genetic testing. Companies are contributing de-identified variant data to public health databases such as ClinVAR and the SEER Cancer Registries. These efforts, supported by cancer research registries, deepen insights and expedite advancements in patient care.
The analysis of expansive data sets is crucial for understanding diseases, allowing researchers to access, assess, and test hypotheses. This collaborative approach is paving the way for tailored treatment plans and new biological discoveries, enhancing early disease detection and intervention.
Integration with Electronic Health Records
Integrating genetic testing with Electronic Health Records (EHR) is another key strategy for improving patient outcomes. Collaborations with EHR vendors like Epic, Flatiron, and Athena streamline processes, making it easier for providers to order genetic products, optimize screening protocols, and identify potential pharmacogenetic interactions. Such collaborations break down silos, enhancing data exchange for more effective research and patient care.
Challenges and Future Trends
Despite the promising progress, the integration of genetic testing into mainstream medicine presents challenges, including managing the vast volume of genomic data. Companies are focusing on presenting complex clinical interpretations, integrating common data ontologies, overcoming data fragmentation, and ensuring data privacy to address these hurdles.
Looking ahead, the industry anticipates significant advancements, with trends like developing tests for early cancer recurrence detection and embracing a multi-omics approach that integrates RNA, proteins, and AI insights. The integration of generative AI for documentation and genetic counseling is another notable development on the horizon.
A New Era in Healthcare
Genetic testing represents more than just a scientific advancement; it signifies a fundamental shift in how we approach health and wellness. As public understanding grows and technology advances, we find ourselves at the dawn of a new era in healthcare, where our genetic code becomes a roadmap to better health and longevity.
About the Author
Kevin Haas, Ph.D., serves as the Chief Technology Officer at Myriad Genetics, where he leads the development of the precision medicine platform. With expertise in molecular simulation and machine learning, Haas is advancing genomics and digital patient/provider experiences. He has co-authored 16 peer-reviewed publications and nine patent applications, bringing a wealth of experience to his role.
More Articles
Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!
Chat‑driven AI tools now let real estate professionals edit listing photos instantly—removing clutter, brightening rooms, updating décor, and even virtually staging a space using simple text prompts. This speed and flexibility help agents create stronger first impressions, accelerate turnover, and present properties more honestly and attractively. With interactive tools becoming common on property sites and transparent editing standards emerging, AI photo enhancement is quickly becoming an essential part of modern real estate marketing.
The commercial real estate landscape is heading into 2026 with powerful momentum and a fresh set of challenges. PwC’s latest Emerging Trends report places Jersey City and North Jersey among the top U.S. markets to watch, driven by redevelopment energy, tech‑driven infrastructure needs, and the surge of mixed‑use communities. But developers also face rising construction costs, high interest rates, and municipal fatigue that’s stalling projects statewide. From booming demand for data centers to the transformation of retail corridors and the rise of community‑based health care facilities, the year ahead is set to redefine how—and where—growth happens.
The Federal Reserve has lowered rates to their lowest level since 2022, marking the third cut in four months and setting the stage for gradual downward pressure on mortgage rates in 2026. While mortgage rates don’t drop automatically when the Fed cuts, easing inflation and a softening 10‑year Treasury yield suggest improved affordability, renewed refinancing opportunities and a more active market ahead for real estate and mortgage professionals.
New research reveals that a growing share of Gen Z no longer believes homeownership is within reach, leading to major behavioral changes. With first-time buyer age nearing 40 and affordability hitting new lows, young adults are saving less, working less, and taking on riskier investments. Studies from Northwestern and the University of Chicago show that when the dream of owning a home feels impossible, motivation declines—and financial priorities shift dramatically.
The FTC has issued warning letters to 13 rental software companies over concerns that their systems may hide mandatory fees and prevent landlords from displaying accurate rental prices. While not formal allegations, the move signals rising federal scrutiny following major enforcement actions against Greystar, RealPage, and Invitation Homes. For real estate professionals, this development highlights the growing importance of transparent pricing, ethical advertising, and staying ahead of regulatory shifts in today’s tech‑driven rental market.
A New York man employed only as a driver for a hedge fund founder allegedly reinvented himself as a seasoned investment professional, convincing three investors to trust him with their money. According to the SEC’s complaint, he created a deceptive LLC, used firm marketing materials to appear legitimate, and conducted risky, unauthorized trades that wiped out accounts. The scheme left the victims with more than $1 million in combined losses, prompting the SEC to pursue fraud charges and a permanent industry ban.
